ARTICLE | Company News
Genelabs, Mitsubishi Tanabe Pharma deal
December 3, 2007 8:00 AM UTC
The companies ended a 2004 deal under which Mitsubishi Tanabe had exclusive Japanese rights to GNLB's Prestara prasterone ( Anastar in Europe) to treat systemic lupus erythematosus (SLE) (see BioCent...